Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018-2020

• Main Authors: Pasquale Stefanizzi (Author), Francesco Paolo Bianchi (Author), Andrea Martinelli (Author), Antonio Di Lorenzo (Author), Paola De Petro (Author), Giusi Graziano (Author), Sabrina Lattanzio (Author), Giusy Diella (Author), Paolo Stella (Author), Domenica Ancona (Author), Silvio Tafuri (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

MenB-FHBp was licensed in Europe in 2017 from the age of 10. In the "postmarketing life" of a new vaccine, surveillance of Adverse Events Following Immunization (AEFI) is crucial, to better understand the pattern of safety and the effectiveness. This paper describes the MenB-FHBp AEFIs not...